Telehealth in Cancer Care: Strategies for Equitable Implementation in New York State
The U.S. telehealth landscape was undeniably transformed by the COVID-19 pandemic, including in the context of cancer care. But what happens next and where do we go from here? Over the course of several months, the Center for Health Law & Policy Innovation of Harvard Law School talked with a diverse group of cancer care stakeholders in New York State about opportunities, challenges, and policy considerations surrounding the future of telehealth implementation—and ensuring that we center equity in our efforts.
On May 14th, join the Center for Health Law and Policy Innovation (CHLPI) for a review of key findings from this research. Attendees will also hear perspectives from representatives of the New York State Department of Health and Memorial Sloan Kettering Cancer Center’s Immigrant Health and Cancer Disparities Center. The target audience for this webinar includes representatives of: cancer centers and other health care systems, health care providers, cancer support services, policymakers, and patient advocates.
Time: 11 a.m. – 12 noon E.T.
Moderator: Rachel Landauer, JD, MPH, Clinical Instructor, Health Law and Policy Clinic, Center for Health Law and Policy Innovation, Harvard Law School
Presenters:
- Leeza Menon: Project Manager, Access to Telehealth Initiative, Memorial Sloan Kettering Cancer Center
- Casey De Bellis, Program Research Specialist, New York State Department of Health – Bureau of Health Access, Policy, and Innovation
- Joshua Budhu, MD, Neuro-Oncologist, Health Equity Researcher, Memorial Sloan Kettering Cancer Center
- Francesca Gany, MD, Founding Chief, Memorial Sloan Kettering Immigrant Health and Cancer Disparities Center
- Sara Raza, Clinical Fellow, Health Law and Policy Clinic, Center for Health Law and Policy Innovation, Harvard Law School
Register here.
This work is made possible with the generous support of the Bristol Myers Squibb Foundation.
